S2Medical AB (S2M) — Cash Flow-to-Debt Ratio
S2Medical AB (S2M) has a Cash Flow-to-Debt Ratio of 0.10x as of December 2025, meaning its operating cash flow of Skr676.00K could theoretically repay 0% of its total liabilities (Skr6.90 Million) in one year. Check S2M cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
S2Medical AB Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for S2Medical AB across 10 annual periods. Also explore S2Medical AB (S2M) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for S2Medical AB (2016–2025)
Year-by-year debt coverage analysis for S2Medical AB. For market capitalisation and broader financial context, see S2Medical AB (S2M) total market value.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | Skr675.00K | Skr6.90 Million | ▼ -87.8% |
| 2024 | 0.80x | Skr5.03 Million | Skr6.29 Million | ▲ +195.7% |
| 2023 | -0.84x | Skr-16.52 Million | Skr19.75 Million | ▲ +45.8% |
| 2022 | -1.54x | Skr-28.13 Million | Skr18.22 Million | ▼ -17.7% |
| 2021 | -1.31x | Skr-19.67 Million | Skr15.00 Million | ▲ +12.8% |
| 2020 | -1.50x | Skr-12.75 Million | Skr8.48 Million | ▲ +50.8% |
| 2019 | -3.05x | Skr-17.10 Million | Skr5.60 Million | ▼ -32.5% |
| 2018 | -2.31x | Skr-12.75 Million | Skr5.53 Million | ▼ -49.8% |
| 2017 | -1.54x | Skr-5.85 Million | Skr3.80 Million | ▼ -86.6% |
| 2016 | -0.82x | Skr-3.03 Million | Skr3.67 Million | — |